Schizophrenia Still Linked to Early Mortality
Long-term results still show higher mortality among patients with schizophrenia vs the general population. Substance use is a main predictor of mortality, and suicide accounted for 27.5% of all deaths.
Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Long-term results still show higher mortality among patients with schizophrenia vs the general population. Substance use is a main predictor of mortality, and suicide accounted for 27.5% of all deaths.
The agency defended approval of brexpiprazole (Rexulti) for the treatment of agitation, saying the antipsychotic fills an unmet medical need.
By Natalie Matosin, Jess Nithianantharajah, Brian Dean, et al., Published on 01/01/23
Are the antipsychotics. medications that can increase their probability to -- they can kill them. >> the doctor gave us medicine for him, but he start to be like a zombie. >> reporter: she had an idea for older patients like joseph based upon what she had seen with some of the youngest. >> when i saw that ka nan boyds are approved for epilepsy and children, i thought, if it can help here, they might help in the behavioral disturbances of dementia. >> reporter: it was a simple theory. during a serizure, the brain ha
1. For patients with schizophrenia, symptomatic response to antipsychotic medication at 2 and 4 weeks after initiation can appropriately predict non-response at 8 weeks, varying by baseline severity and specific antipsychotic trialed. Evidence Rating Level: 1 (Excellent) For patients with schizophrenia trialed on antipsychotic medication, it is unclear when to switch medication for failed responses,